An increase in activation of JNK and p38 mitogen-activated protein kinase (MAPK) is noticeable in AD postmortem brains, suggesting a possible linkage between dysregulation of MAPK signaling pathway and AD pathogenesis [88]. The gene discussed is MAPK14; the disease is Alzheimer disease.